von Eiff M, Fischer E
Med Klin (Munich). 1989 May 15;84(5):246-51.
Over the past two decades patients with acute myocardial infarction have been treated with intravenous streptokinase therapy at the hospital in Geldern. Based on experiences in the first study from 1970 to 1979, the second study emphasized instruction on early thrombolytic therapy. Informations were given to general practitioners and to patients at risk for acute myocardial infarction. In the study from 1980 to 1985 the percentage of patients with acute myocardial infarction being treated with thrombolytic agents within two hours after the acute event was 69%. Patients with a duration of ischemia of less than two hours had a significantly decreased in-hospital mortality compared to patients who received therapy more than two hours after onset of symptoms. We conclude that intensified information and instruction of physicians and of patients at risk for myocardial infarction enables early thrombolytic therapy and results in reduced in-hospital mortality of acute myocardial infarction.
在过去二十年中,盖尔德恩医院一直采用静脉注射链激酶疗法治疗急性心肌梗死患者。基于1970年至1979年第一项研究的经验,第二项研究强调了早期溶栓治疗的指导。相关信息提供给了全科医生以及有急性心肌梗死风险的患者。在1980年至1985年的研究中,急性事件发生后两小时内接受溶栓药物治疗的急性心肌梗死患者比例为69%。与症状发作两小时后才接受治疗的患者相比,缺血持续时间少于两小时的患者院内死亡率显著降低。我们得出结论,加强对医生和有心肌梗死风险患者的信息告知和指导能够实现早期溶栓治疗,并降低急性心肌梗死的院内死亡率。